All Pharma News
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BUSINESSWIRE
02 Apr 2024
Share Share
Syros Reports Fourth Quarter and Full Year 2023 Financial Results

Syros Reports Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
27 Mar 2024
Share Share
Syros to Participate in TD Cowen 44th Annual Health Care Conference

Syros to Participate in TD Cowen 44th Annual Health Care Conference
BUSINESSWIRE
27 Feb 2024
Share Share
Syros Highlights 2024 Milestones to Deliver on the Value of Tamibarotene

Syros Highlights 2024 Milestones to Deliver on the Value of Tamibarotene
BUSINESSWIRE
08 Jan 2024
Share Share
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock

Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock
BUSINESSWIRE
19 Dec 2023
Share Share
Syros’ stock up after sharing early, mid-stage AML data

Syros’ stock up after sharing early, mid-stage AML data
Gabrielle Masson FIERCE BIOTECH
07 Dec 2023
Share Share
Syros Announces Initial Data from Phase 2 Trial Evaluating Tamibarotene

Syros Announces Initial Data from Phase 2 Trial Evaluating Tamibarotene
BUSINESSWIRE
06 Dec 2023
Share Share
Syros Announces Planned CEO Leadership Transition

Syros Announces Planned CEO Leadership Transition
BUSINESSWIRE
02 Oct 2023
Share Share
After 2 partners walk away, Syros cuts 35% of workforce

After 2 partners walk away, Syros cuts 35% of workforce
Annalee Armstrong FIERCE BIOTECH
02 Oct 2023
Share Share
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BUSINESSWIRE
07 Sep 2023
Share Share